Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
20.62
-1.06 (-4.89%)
At close: Oct 30, 2026, 4:00 PM EDT
20.33
-0.29 (-1.41%)
After-hours: Oct 30, 2026, 7:31 PM EDT
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $567.37 million as of October 30, 2026. It is the 13,391st most valuable company in the world and the 2,645th biggest in the United States. Its market cap has decreased by 18.45% in one year.
Market Cap
567.37M
Enterprise Value
25.62M
1-Year Change
-18.45%
Global Rank
Country Rank
#2,645 United States
Category
ChartMarket Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $567.37M, an increase of 262.53%. That is a compound annual growth rate of 13.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 567.40M | -30.13% |
| Dec 31, 2025 | 812.10M | 43.76% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoGenomics | 2.25B |
| GeneDx Holdings | 2.06B |
| Personalis | 1.69B |
| Freenome | 1.34B |
| OPKO Health | 1.24B |
| Castle Biosciences | 1.14B |
| Myriad Genetics | 607.38M |
| Biodesix | 245.37M |